What does it mean that medical insurance is limited to class B drugs?

Class B drugs restricted by medical insurance refer to drugs with limited payment scope in the medical insurance catalogue. Although these drugs are considered to have certain therapeutic effects, their safety, effectiveness and economy need to be further confirmed compared with Class C drugs. Therefore, under the premise of ensuring the safety of patients' medication, the scope of medical insurance payment is scientifically restricted and excluded.

The purpose of defining medical insurance as Class B drugs is to avoid patients from having to bear the huge economic pressure of drug prices because of the increase in medical expenses caused by the inclusion of unnecessary expensive drugs in the scope of medical insurance payment. By limiting the payment of Class B drugs, under the premise of reasonably controlling the scope of medical insurance drugs, it can help patients reduce the cost of medication and effectively control the overall expenditure of medical expenses.

It should be noted that medical insurance is limited to Class B drugs, which does not mean that these drugs have no therapeutic effect in practical application. In the case that the pathogenic mechanism and drug action mechanism are relatively clear, it is necessary to limit the use and payment accordingly. Therefore, when using drugs, doctors should weigh the advantages and disadvantages according to the specific situation of patients, so as to get the best treatment plan, encourage the implementation of rational drug use, and jointly promote the healthy development of medical insurance system construction.